Genetic predictors of cardiovascular toxicity in oncohematological patients

QR Code

Genetic predictors of cardiovascular toxicity in oncohematological patients

Aim. To identify single nucleotide polymorphisms reliably associated with cardiovascular toxicity in oncohematological patients receiving antitumor immunochemotherapy.Material and methods. For the study, 34 patients with an established diagnosis of non-Hodgkin's B-cell follicular lymphoma were...

Full description

Saved in:

Bibliographic Details
Main Authors:	G. R. Gimatdinova, O. E. Danilova, I. L. Davydkin, Yu. S. Milyutkina, A. S. Sustretov, O. A. Germanova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2024-11-01
Series:	Российский кардиологический журнал
Subjects:	cardiovascular toxicity cardiotoxicity genetics polymorphisms gene lymphoma
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/6081
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Genetic polymorphisms associated with the development of arrhythmic type of cardiovascular events
by: G. R. Gimatdinova, et al.
Published: (2022-09-01)

Molecular genetic markers of chemotherapy-induced cardiotoxicity in patients with oncohematological diseases (review)
by: Yu. S. Milyutkina, et al.
Published: (2023-12-01)

Possibilities of Predicting Methotrexate-associated Toxicity in Oncohematology Based on Molecular Genetic Testing Methods
by: Zarui K. Simavonyan, et al.
Published: (2024-11-01)

Genetic polymorphisms as predictors of methotrexate toxicity: literature review
by: G. A. Radzhabova, et al.
Published: (2024-04-01)

Cardiovascular toxicity of antitumor therapy: effect on myocardial and vascular remodeling
by: Yu. Yu. Kirichenko, et al.
Published: (2021-11-01)

Potential New Applications of Sodium–Glucose Cotransporter-2 Inhibitors Across the Continuum of Cancer-Related Cardiovascular Toxicity
by: Agnieszka Maria Zebrowska, et al.
Published: (2025-06-01)

Treatment patterns, outcomes and long-term toxicity among patients with Hodgkin’s lymphoma in real world: results of a hospital based registry
by: E. A. Nikitin, et al.
Published: (2016-10-01)

Prognostic value of vascular remodeling parameters in the development of adverse cardiovascular events in patients with gastric cancer
by: Y. Yu. Kirichenko, et al.
Published: (2022-12-01)

Cardiovascular system state changes in non-Hodgkin’s lymphoma patients during chemotherapy
by: A.-S. O. Bady, et al.
Published: (2020-05-01)

Diagnostic capabilities of instrumental methods for studying early cardiovascular adverse events in patients with lymphoproliferative disorders, quality and safety issues
by: G. R. Gimatdinova, et al.
Published: (2024-03-01)

THE GENETIC SUSCEPTIBILITY TO ATHEROSCLEROSIS
by: T. V. Kozhanova, et al.
Published: (2018-12-01)

Advances in Genetic Polymorphism Research in Rosacea: Mechanisms and Clinical Implications
by: Wang Z, et al.
Published: (2025-06-01)

The role of <i>Helicobacter pylori</i> in cardiovascular toxicity mechanisms
by: A. A. Avagimyan, et al.
Published: (2019-12-01)

Molecular genetic markers of atrial fibrillation
by: A. V. Ponasenko, et al.
Published: (2020-04-01)

Pharmacogenetics in treatment of anthracycline-induced cardiotoxicity in women without prior cardiovascular diseases
by: E. V. Grakova, et al.
Published: (2023-01-01)

Genetic basis of anthracyclines cardiotoxicity: Literature review
by: M. Yu. Sinitsky, et al.
Published: (2021-10-01)

Cardiac toxicity in children and adolescents with Hodgkin lymphoma after chemoradiotherapy
by: R. I. Feoktistov, et al.
Published: (2022-11-01)

Early toxicity of high-dose methotrexate in the treatment of non-hodgkin lymphomas in children
by: Z. K. Simavonyan, et al.
Published: (2025-03-01)

CARDIOVASCULAR COMPLICATIONS OF ANTITUMOR THERAPY FOR BREAST CANCER: DIAGNOSIS, PREVENTION AND TREATMENT
by: V. I. Potievskaya, et al.
Published: (2021-10-01)

Microarrays: a new era in development of oncohematology
by: Ye. A. Nikitin, et al.
Published: (2022-11-01)

Polymorphism of ACE, AGT, AGTR1 genes as genetic predictors of hypertension
by: A. Yu. Elkina, et al.
Published: (2021-04-01)

MOLECULAR GENETIC TESTING OF OSTEOPOROSIS SUSCEPTIBILITY IN POSTMENOPAUSAL WOMEN IN MOSCOW
by: V A Myakotkin, et al.
Published: (2011-04-01)

Therapeutic Potential of Ginsenosides in Anthracycline-Induced Cardiotoxicity
by: Rongrong Bai, et al.
Published: (2025-06-01)

Associations of Cardiovascular Risk Factors and Genetic Markers with Development of Arterial Hypertension in the Population of Mountain Shoriya
by: T. A. Mulerova, et al.
Published: (2018-11-01)

Approaches to early diagnosis and prevention of cardiovascular toxicity induced by targeted drugs and immune checkpoint inhibitors in oncohematology: a literature review
by: N. S. Mescherina, et al.
Published: (2023-02-01)

GENETIC PREDICTORS OF ATRIAL FIBRILLATION
by: A. V. Kuskaeva, et al.
Published: (2016-06-01)

Molecular genetic indicators of the probability of early myocardial systolic dysfunction signs in doxorubicin chemotherapy in patients with breast cancer of moderate and low HFA-ICOS risk groups
by: I. A. Karput, et al.
Published: (2024-11-01)

Micro-RNA as a predictor of cardiovascular diseases
by: U. A. Khalilova, et al.
Published: (2021-09-01)

Clinical and cost-effectiveness of pharmacogenomic testing for anthracycline-induced cardiotoxicity in childhood cancer: a systematic review and meta-analysis
by: Ling Yin Fritz Wong, et al.
Published: (2025-07-01)

Cardiotoxicity of Anticancer Drugs
by: I. Maiborodin, et al.
Published: (2025-02-01)

Investigating the Interplay of Toxic Metals and Essential Elements in Cardiovascular Disease
by: Aderonke Gbemi Adetunji, et al.
Published: (2025-05-01)

Exploring genetic predictors of naltrexone treatment response in opioid use disorder
by: Е. A. Blokhina ., et al.
Published: (2019-12-01)

GENETIC POLYMORPHISMS AS THE RISK FACTOR IN THE DEVELOPMENT OF OSTEOARTHRITIS
by: S. B. Panina
Published: (2014-06-01)

Treatment of advanced Hodgkin lymphomas in adolescents and young adults: efficacy and toxicity issues
by: Yu. V. Larina, et al.
Published: (2014-07-01)

Genetic aspects of lactase deficiency in indigenous populations of Siberia
by: B. A. Malyarchuk
Published: (2024-10-01)

The cardiovascular system in patients with anthracycline cardiomiopathy
by: Alexandr T. Teplyakov, et al.
Published: (2017-10-01)

Contribution of the <i>OLR1</i> gene to the development of cardiovascular diseases
by: V. M. Pisarev, et al.
Published: (2024-11-01)

GENETIC PREDICTORS OF SEVERITY AND EFFICACY OF COVID-19 PHARMACOTHERAPY
by: I. N. Shishimorov, et al.
Published: (2021-08-01)

Gonadal toxicity of Hodgkin lymphoma treatment in adolescents and young males: issue relevance and ways of solve (literature review)
by: A. A. Vinokurov, et al.
Published: (2014-07-01)

ROLE OF POLYMORPHISMS OF TOLL-LIKE RECEPTORS SIGNALING PATHWAY GENES IN THE DEVELOPMENT OF HEMATOLOGICAL MALIGNANCIES
by: E. L. Nazarova, et al.
Published: (2017-09-01)